/NEPTF
NEPTF Stock - Neptune Wellness Solutions Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
39
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.22
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NEPTF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.44
52W High$0.03
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $52.62M | $48.80M | $28.16M | $14.75M | $13.67M |
| Gross Profit | $-2,474,165 | $-7,536,346 | $-21,778,694 | $-916,531 | $4.26M |
| Gross Margin | -4.7% | -15.4% | -77.3% | -6.2% | 31.2% |
| Operating Income | $-102,847,698 | $-88,529,881 | $-104,124,068 | $-77,233,948 | $-12,762,858 |
| Net Income | $-60,459,666 | $-74,971,745 | $-97,995,299 | $-30,342,509 | $-12,974,608 |
| Net Margin | -114.9% | -153.6% | -347.9% | -205.8% | -94.9% |
| EPS | $-8192.00 | $-24864.00 | $-39597.51 | $0.00 | $0.00 |
Company Overview
Neptune Wellness Solutions Inc. operates as a consumer packaged goods company in Canada, the United States, and internationally. It's product portfolio includes omega-3 fish oils and other nutritional products, as well as softgel solutions under the Biodroga brand; and provides MaxSimil, an omega-3 fatty acid delivery technology that uses enzymes to predigest omega-3 fatty acids. The company offers vegan multi-omega gummies and soft gels under the Forest Remedies brand; and organic baby food products under the Sprout brands. It offers its products through distributors, retail outlets, and grocery stores, as well as online on forestremedies.com and sproutorganics.com, and e-commerce sites. Neptune Wellness Solutions Inc. was incorporated in 1998 and is headquartered in Laval, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NEPTFBeat Rate
100%
Last 6 quarters
Avg Surprise
+85.7%
EPS vs Estimate
Beats / Misses
6/0
Last 12 quarters
Latest EPS
$-4.14
Q1 2024
EPS Surprise History
Q2 22
+100.0%
$-0.02vs$-73.44
Q3 22
No data
Q4 22
+100.2%
$0.12vs$-50.96
Q1 23
+92.5%
$-2.21vs$-29.68
Q1 23
No data
Q2 23
+95.4%
$-0.51vs$-11.23
Q4 23
+84.5%
$-1.38vs$-8.87
Q1 24
+41.6%
$-4.14vs$-7.09
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 4, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q1 2025 | Feb 28, 2025 | — | — | — | — |
Q4 2024 | Nov 15, 2024 | — | — | — | — |
Q3 2024 | Aug 28, 2024 | — | — | — | — |
Q1 2024 | Mar 28, 2024 | — | — | — | — |
Q1 2024 | Feb 16, 2024 | $-7.09 | $-4.14 | +41.6% | ✓ BEAT |
Q4 2023 | Nov 15, 2023 | $-8.87 | $-1.38 | +84.5% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $-11.23 | $-0.51 | +95.4% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | — | $-2.21 | — | — |
Q1 2023 | Mar 31, 2023 | $-29.68 | $-2.21 | +92.5% | ✓ BEAT |
Q4 2022 | Dec 31, 2022 | $-50.96 | $0.12 | +100.2% | ✓ BEAT |
Q3 2022 | Sep 29, 2022 | — | $-3.94 | — | — |
Q2 2022 | Jun 29, 2022 | $-73.44 | $-0.02 | +100.0% | ✓ BEAT |
Q4 2021 | Dec 30, 2021 | — | $-3.10 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-3.10 | — | — |
Q3 2021 | Sep 29, 2021 | — | $-2.11 | — | — |
Q3 2021 | Sep 29, 2021 | — | $-2.11 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-3.53 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-3.53 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NEPTF
What is NEPTF's current stock price?
Neptune Wellness Solutions Inc. (NEPTF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for NEPTF?
No analyst price targets are currently available for this stock.
What sector is Neptune Wellness Solutions Inc. in?
Neptune Wellness Solutions Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is NEPTF's market cap?
Neptune Wellness Solutions Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does NEPTF pay dividends?
No, Neptune Wellness Solutions Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACUS
Acusphere, Inc.
$0.00
Mkt Cap: $0.0B
AQSZF
Aequus Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
DVLP
Golden Developing Solutions, Inc.
$0.00
Mkt Cap: $0.0B
EVARF
Lombard Medical, Inc.
$0.00
Mkt Cap: $0.0B
IVIXF
Invion Limited
$0.04
Mkt Cap: $0.0B
MCIC
MultiCorp International, Inc.
$0.00
Mkt Cap: $0.0B
NXEN
Nexien BioPharma, Inc.
$0.00
Mkt Cap: $0.0B
RGMP
Regnum Corp.
$0.00
Mkt Cap: $0.0B
RMRK
Rimrock Gold Corp.
$0.00
Mkt Cap: $0.0B
XTXXF
Adastra Holdings Ltd.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to NEPTF for comparison